Trial intelligence / Profile preview

Sertraline in depressed patients with aggressive behavior

IRCT201411122999N4Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of sertraline in major depressive disorder (MDD), sponsored by Tabriz University of Medical Sciences. Started Mar 2015; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on IRCT201411122999N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201411122999N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call